Genmab · 1 day ago
Associate Director, Biostats
Princeton, NJ
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
$147K/yr - $220K/yr
8+ years expGenmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Associate Director acts as a statistical expert supporting clinical development, contributing to strategies and plans while ensuring consistency and quality in statistical methods across trials.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Act as lead and main point of contact related to Statistics for designated compound/indication
Follow scientific and technical progress within the field of biostatistics in drug development and advise of new methodologies that may support innovation and improve efficiencies
Engage with regulatory authorities on compound/indication level discussions
Acts as a role model
Ensures consistency of statistical methods and data handling across trials
Ensures all compound/indication related work and information is shared between biostatisticians involved in the compound and with the vendor
Supports compound responsible programmer in developing an integrated database specification
Responsible for giving statistical input to overall strategy and the synopsis development in the CDT
Provide scientific advice to the CDT including design of trials, analyses and analyses requiring advanced statistical methodologies/techniques
Represent the CDT/the company at regulatory meetings, during Key Opinion Leaders meetings, network and/or Partner meetings, as applicable
Drive design and synopsis development together with relevant stakeholders
Ensure transparent communication to relevant stakeholders from the CDT
Ensure availability of integrated database(s), as needed, and planning and conduct of integrated analysis to support development decisions, submissions, and marketing needs
Support development and communication in relation to communication strategy and/or scientific input to presentations, posters, and articles
Represent Genmab during meetings/congresses and courses and perform professional networking
Engage with regulatory authorities on trial level discussions
Arranges/attends lessons learned to share learnings
Represents Genmab during Key Opinion Leaders meetings
Ensure biostatistician review of partner synopsis, protocols, statistical analysis plans, results meetings presentations and clinical trial reports
Coordinate data transfers from/to business partners in collaboration with the programmer and the data manager, as applicable
Ensures state of the art statistical work which includes but is not limited to:
Applying adequate methods for which a solid scientific foundation exists
Ensure proper documentation of work done
Keep oversight and QC essential documents/data provided by vendors
Ensure trial related work is performed in accordance with Genmab SOP/processes and standards and ICH-GCP
Participate and represent Biostatistics
Review and provide input to protocol and amendment development
Perform vendor oversight according to applicable SOPs
Give input to eCRF setup, edit checks, validation plan, protocol deviations classifications, DSUR, IB updates, tables, figures, and listings etc
Review assay validation reports, as applicable
Perform exploratory analysis, ad hoc analyses, and modelling of data
Review and approve randomization and stratification plans
Perform UAT of Randomization part of the IRT system as applicable
Ensure procedures for blinding are in place as applicable
Support timely delivery of statistical deliverables
Responsible for planning and conducting trial result meetings
Review and approve the CSR
Attend trial and investigator meetings if/as needed
Collaboration with Genmab Global Drug Safety:
Participate in definition, review, and approval of data packages for Data Monitoring Committees
Review and approve any amendments, corrections, and updates of data packages
Support regulatory submission/filing activities
Qualification
Required
Master's or PhD in a statistical discipline
Experience in statistical analysis, modelling and simulation and adaptive trial designs
Experience directing multiple complex projects/studies in a technical capacity
Proven performance in earlier role/comparable role
Preferred
8+ years of experience in relevant area preferred, or demonstrated capability
Experience with drug development in biologics, targeted therapies, and companion diagnostics preferred
Experience working with FDA, EMA, and ICH guidance for drug development pertaining to statistics
Experience with the relevant regulatory requirements for biostatistics processes and SOPs
Experience with regulatory submissions including BLAs and previous experience in dealing with Health authorities such as discussions/negotiations in filing strategies
Experience working with SDTM, ADaM, eSUB, and CDISC requirements for regulatory submissions
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
1001-5000 employees
H1B Sponsorship
Genmab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
Pharma Letter
2026-01-09
2026-01-09
2026-01-08
Company data provided by crunchbase